Other Popular Peptides in the Gray Zone: Thymosin Alpha-1 Immune support (approved in 35+ countries, NOT in US) GHK-Cu (Copper Peptide) Skin/hair (injectable form banned by FDA) Epitalon Claimed anti-aging (no human studies) LL-37 Antimicrobial (research only) AOD-9604 Fat loss (FDA banned) Semorelin Growth hormone release Melanotan II Tanning (serious side effects) The FDA Crackdown: What Happened in Late 2023 Timeline of the Ban: 2023: FDA adds 12+ peptides to "Category 2 Bulk Drug Substances" list What this means: Compounding pharmacies CANNOT legally make these peptides FDA cites "significant safety risks" No approved use in humans Peptides specifically banned from compounding: BPC-157 TB-500 (Thymosin Beta-4 fragment) Thymosin Alpha-1 CJC-1295 Ipamorelin AOD-9604 GHK-Cu (injectable) Epitalon LL-37 DSIP KPV Selank Semax And more
Regulation of neutrophil degranulation and cytokine secretion: a novel model approach based on linear fitting
Treatment is delivered in a series of injections and can be combined with other therapies such as PRP or shockwave therapy
Instead, they seem built to help startups, med spas, wellness brands, and developing beauty businesses move from idea to product in a way that feels structured, compliant, and commercially realistic
Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on the Combination of Metformin and Insulin A total of 641 patients with type 2 diabetes participated in a 24-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of sitagliptin as add-on to insulin therapy
Journal of Cosmetic Dermatology [Internet]
